FDA Suggests Preoperational Review Meetings Before Submitting NDAs For Continuous Manufacturing
This article was originally published in The Gold Sheet
FDA suggests early site visits before submitting NDAs and supplements for continuous manufacturing to smooth over rough patches before pre-approval inspections. Agency also shares some insights on what inspectors will be looking for during PAIs of continuous manufacturing facilities.
Register for our free email digests: